 | • レポートコード：QFJ1-5693 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、認知症＆アルツハイマー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コリンエステラーゼ阻害剤、メマンチン、併用薬）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・認知症＆アルツハイマー病治療の市場動向 ・企業の競争状況、市場シェア ・認知症＆アルツハイマー病治療の種類別市場規模と予測2016-2027（コリンエステラーゼ阻害剤、メマンチン、併用薬） ・認知症＆アルツハイマー病治療の用途別市場規模と予測2016-2027（病院、診療所） ・認知症＆アルツハイマー病治療の北米市場規模2016-2027（アメリカ、カナダ） ・認知症＆アルツハイマー病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・認知症＆アルツハイマー病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・認知症＆アルツハイマー病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・認知症＆アルツハイマー病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Pfizer, Inc.、AbbVie Inc.、Allergan plc、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、AstraZeneca、Biogen、Eisai Co., Ltd.、INmuneBIO） ・結論 |
Alzheimer’s disease is a chronic neurodegenerative disorder which results in gradual degradation of the tissues of the brain. This hampers the normal functioning of the brain and impacts the daily lives of patients.
Market Analysis and Insights: Global Dementia and Alzheimer’s Disease Treatment Market
The global Dementia and Alzheimer’s Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dementia and Alzheimer’s Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dementia and Alzheimer’s Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dementia and Alzheimer’s Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dementia and Alzheimer’s Disease Treatment market.
Global Dementia and Alzheimer’s Disease Treatment Scope and Market Size
Dementia and Alzheimer’s Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dementia and Alzheimer’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cholinesterase Inhibitors
Memantine
Combination Drugs
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Pfizer, Inc.
AbbVie Inc.
Allergan plc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
AstraZeneca
Biogen
Eisai Co., Ltd.
INmuneBIO
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cholinesterase Inhibitors
1.2.3 Memantine
1.2.4 Combination Drugs
1.3 Market by Application
1.3.1 Global Dementia and Alzheimer’s Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dementia and Alzheimer’s Disease Treatment Market Perspective (2016-2027)
2.2 Dementia and Alzheimer’s Disease Treatment Growth Trends by Regions
2.2.1 Dementia and Alzheimer’s Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dementia and Alzheimer’s Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dementia and Alzheimer’s Disease Treatment Industry Dynamic
2.3.1 Dementia and Alzheimer’s Disease Treatment Market Trends
2.3.2 Dementia and Alzheimer’s Disease Treatment Market Drivers
2.3.3 Dementia and Alzheimer’s Disease Treatment Market Challenges
2.3.4 Dementia and Alzheimer’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dementia and Alzheimer’s Disease Treatment Players by Revenue
3.1.1 Global Top Dementia and Alzheimer’s Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dementia and Alzheimer’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dementia and Alzheimer’s Disease Treatment Revenue
3.4 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio
3.4.1 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dementia and Alzheimer’s Disease Treatment Revenue in 2020
3.5 Dementia and Alzheimer’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Dementia and Alzheimer’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Dementia and Alzheimer’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dementia and Alzheimer’s Disease Treatment Breakdown Data by Type
4.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Dementia and Alzheimer’s Disease Treatment Breakdown Data by Application
5.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
6.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type
6.2.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
6.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application
6.3.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
6.4 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country
6.4.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
7.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type
7.2.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application
7.3.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country
7.4.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
9.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type
9.2.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application
9.3.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country
9.4.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Dementia and Alzheimer’s Disease Treatment Introduction
11.1.4 Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Details
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Introduction
11.2.4 Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.2.5 Pfizer, Inc. Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Details
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Introduction
11.3.4 AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.3.5 AbbVie Inc. Recent Development
11.4 Allergan plc
11.4.1 Allergan plc Company Details
11.4.2 Allergan plc Business Overview
11.4.3 Allergan plc Dementia and Alzheimer’s Disease Treatment Introduction
11.4.4 Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.4.5 Allergan plc Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Introduction
11.5.4 Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 F. Hoffmann-La Roche Ltd.
11.6.1 F. Hoffmann-La Roche Ltd. Company Details
11.6.2 F. Hoffmann-La Roche Ltd. Business Overview
11.6.3 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
11.6.4 F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.6.5 F. Hoffmann-La Roche Ltd. Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Dementia and Alzheimer’s Disease Treatment Introduction
11.7.4 AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Biogen
11.8.1 Biogen Company Details
11.8.2 Biogen Business Overview
11.8.3 Biogen Dementia and Alzheimer’s Disease Treatment Introduction
11.8.4 Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.8.5 Biogen Recent Development
11.9 Eisai Co., Ltd.
11.9.1 Eisai Co., Ltd. Company Details
11.9.2 Eisai Co., Ltd. Business Overview
11.9.3 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
11.9.4 Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.9.5 Eisai Co., Ltd. Recent Development
11.10 INmuneBIO
11.10.1 INmuneBIO Company Details
11.10.2 INmuneBIO Business Overview
11.10.3 INmuneBIO Dementia and Alzheimer’s Disease Treatment Introduction
11.10.4 INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
11.10.5 INmuneBIO Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cholinesterase Inhibitors
Table 3. Key Players of Memantine
Table 4. Key Players of Combination Drugs
Table 5. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dementia and Alzheimer’s Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Dementia and Alzheimer’s Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Dementia and Alzheimer’s Disease Treatment Market Share by Regions (2016-2021)
Table 9. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Dementia and Alzheimer’s Disease Treatment Market Share by Regions (2022-2027)
Table 11. Dementia and Alzheimer’s Disease Treatment Market Trends
Table 12. Dementia and Alzheimer’s Disease Treatment Market Drivers
Table 13. Dementia and Alzheimer’s Disease Treatment Market Challenges
Table 14. Dementia and Alzheimer’s Disease Treatment Market Restraints
Table 15. Global Dementia and Alzheimer’s Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players (2016-2021)
Table 17. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2020)
Table 18. Ranking of Global Top Dementia and Alzheimer’s Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dementia and Alzheimer’s Disease Treatment Product Solution and Service
Table 22. Date of Enter into Dementia and Alzheimer’s Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Dementia and Alzheimer’s Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Dementia and Alzheimer’s Disease Treatment Product
Table 65. Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Pfizer, Inc. Company Details
Table 68. Pfizer, Inc. Business Overview
Table 69. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 70. Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 71. Pfizer, Inc. Recent Development
Table 72. AbbVie Inc. Company Details
Table 73. AbbVie Inc. Business Overview
Table 74. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 75. AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 76. AbbVie Inc. Recent Development
Table 77. Allergan plc Company Details
Table 78. Allergan plc Business Overview
Table 79. Allergan plc Dementia and Alzheimer’s Disease Treatment Product
Table 80. Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 81. Allergan plc Recent Development
Table 82. Eli Lilly and Company Company Details
Table 83. Eli Lilly and Company Business Overview
Table 84. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product
Table 85. Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly and Company Recent Development
Table 87. F. Hoffmann-La Roche Ltd. Company Details
Table 88. F. Hoffmann-La Roche Ltd. Business Overview
Table 89. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 90. F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 91. F. Hoffmann-La Roche Ltd. Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Dementia and Alzheimer’s Disease Treatment Product
Table 95. AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Biogen Company Details
Table 98. Biogen Business Overview
Table 99. Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 100. Biogen Recent Development
Table 101. Eisai Co., Ltd. Company Details
Table 102. Eisai Co., Ltd. Business Overview
Table 103. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 104. Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 105. Eisai Co., Ltd. Recent Development
Table 106. INmuneBIO Company Details
Table 107. INmuneBIO Business Overview
Table 108. INmuneBIO Dementia and Alzheimer’s Disease Treatment Product
Table 109. INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 110. INmuneBIO Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dementia and Alzheimer’s Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Cholinesterase Inhibitors Features
Figure 3. Memantine Features
Figure 4. Combination Drugs Features
Figure 5. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Dementia and Alzheimer’s Disease Treatment Report Years Considered
Figure 9. Global Dementia and Alzheimer’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Dementia and Alzheimer’s Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dementia and Alzheimer’s Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Dementia and Alzheimer’s Disease Treatment Market Share by Regions (2022-2027)
Figure 13. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players in 2020
Figure 14. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue in 2020
Figure 16. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
Figure 20. North America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
Figure 21. North America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2016-2027)
Figure 22. United States Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
Figure 26. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
Figure 27. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Country (2016-2027)
Figure 28. Germany Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Share by Region (2016-2027)
Figure 38. China Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 58. Pfizer, Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 59. AbbVie Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 60. Allergan plc Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 64. Biogen Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 65. Eisai Co., Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 66. INmuneBIO Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の認知症治療市場規模・現状・予測（2021年-2027年） Donepezil (also known as Aricept), rivastigmine (Exelon) and galantamine (Reminyl) are used to treat the symptoms of mild to moderate Alzheimer's disease. Market Analysis and Insights: Global Dementia Treatment Market The global Dementia Treatment market size is projected to reach US$ XX million by …- 世界のアルツハイマー病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alzheimer Disease Treatment Market The global Alzheimer Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 世界の認知症ケア製品市場規模・現状・予測（2021年-2027年） The dementia constitutes symptoms such as memory loss, difficulty in problem solving. It is a disease related to brain and decreases thinking ability. The common type of dementia is Alzheimer's disease which constitutes around 65% of the total cases of dementia. Most of dementia problems are slow an…
- アルツハイマー病治療薬のグローバル市場2021 Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Alzheimer’s disease drug are widely used for Early to Moderate, Moderate to Severe stage trea…
- 世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Polycystic Kidney Disease Treatment Drugs Market The global Polycystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…